Europe (WHO region) vs Pakistan: Cases started on MDR-TB treatment
Europe (WHO region)
40,112
in 2024
Pakistan
4,214
in 2024
Europe (WHO region) rank
5th
Pakistan rank
8th
Cases started on MDR-TB treatment over time
- Europe (WHO region)
- Pakistan
How they compare
Europe (WHO region) currently reports 40,112 against 4,214 in Pakistan, a difference of 35,898.
That makes Europe (WHO region)'s figure about 9.5 times Pakistan's.
The two have swapped places 1 time across 17 shared years of data; in 2008 it was Pakistan ahead.
Europe (WHO region) ranks 5th and Pakistan ranks 8th of 11 groups.
Europe (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8,584 | 204 | 8,380 | Europe (WHO region) |
| 2010s | 45,082 | 2,046 | 43,036 | Europe (WHO region) |
| 2020s | 45,324 | 3,347 | 41,977 | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Europe (WHO region) or Pakistan?
- Europe (WHO region), at 40,112 against 4,214 in Pakistan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Europe (WHO region) and Pakistan?
- 35,898, with Europe (WHO region) ahead.
- How many years of comparable data are there for Europe (WHO region) and Pakistan?
- 17 years are reported by both, from 2008 to 2024.
- How do Europe (WHO region) and Pakistan rank globally for cases started on mdr-tb treatment?
- Europe (WHO region) ranks 5th and Pakistan ranks 8th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.